DD127142A5 - - Google Patents

Info

Publication number
DD127142A5
DD127142A5 DD194395A DD19439576A DD127142A5 DD 127142 A5 DD127142 A5 DD 127142A5 DD 194395 A DD194395 A DD 194395A DD 19439576 A DD19439576 A DD 19439576A DD 127142 A5 DD127142 A5 DD 127142A5
Authority
DD
German Democratic Republic
Application number
DD194395A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD127142A5 publication Critical patent/DD127142A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
DD194395A 1975-08-20 1976-08-19 DD127142A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1082275A CH622802A5 (en:Method) 1975-08-20 1975-08-20

Publications (1)

Publication Number Publication Date
DD127142A5 true DD127142A5 (en:Method) 1977-09-07

Family

ID=4367199

Family Applications (1)

Application Number Title Priority Date Filing Date
DD194395A DD127142A5 (en:Method) 1975-08-20 1976-08-19

Country Status (35)

Country Link
US (1) US4069324A (en:Method)
JP (1) JPS5225794A (en:Method)
AR (2) AR215247A1 (en:Method)
AT (1) AT348119B (en:Method)
AU (1) AU501362B2 (en:Method)
BE (1) BE845320A (en:Method)
BG (5) BG27559A4 (en:Method)
CA (1) CA1090331A (en:Method)
CH (5) CH622802A5 (en:Method)
CS (6) CS193584B2 (en:Method)
CY (1) CY1165A (en:Method)
DD (1) DD127142A5 (en:Method)
DE (1) DE2636962A1 (en:Method)
DK (1) DK374576A (en:Method)
ES (1) ES450775A1 (en:Method)
FI (1) FI66619C (en:Method)
FR (1) FR2321293A1 (en:Method)
GB (1) GB1551931A (en:Method)
GR (1) GR61656B (en:Method)
HK (1) HK12083A (en:Method)
HU (1) HU179140B (en:Method)
IE (1) IE43717B1 (en:Method)
IL (1) IL50298A (en:Method)
MY (1) MY8400030A (en:Method)
NL (1) NL7609240A (en:Method)
NO (1) NO152510C (en:Method)
NZ (1) NZ181804A (en:Method)
OA (1) OA05419A (en:Method)
PH (1) PH12931A (en:Method)
PL (4) PL110983B1 (en:Method)
PT (1) PT65494B (en:Method)
RO (7) RO74667A (en:Method)
SE (1) SE437990B (en:Method)
SU (7) SU847923A3 (en:Method)
ZA (1) ZA764980B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5498489U (en:Method) * 1977-12-22 1979-07-11
JPS5418379U (en:Method) * 1978-08-14 1979-02-06
JPS57140307U (en:Method) * 1981-02-27 1982-09-02
SE438477B (sv) * 1983-02-28 1985-04-22 Gote Hakansson Anordning vid vagnar
US4927943A (en) * 1984-09-04 1990-05-22 Bristol-Myers Company Substituted 7-oxomitosanes
EP0720611A1 (en) * 1994-07-22 1996-07-10 Antibioticos S.P.A. Glutaryl 7-aca derivatives and processes for obtaining them
CN103387584B (zh) * 2013-07-17 2015-02-25 盐城开元医药化工有限公司 一种7-氨基-3-氯-3-头孢环-4-羧酸的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
AR208068A1 (es) * 1973-02-23 1976-11-30 Lilly Co Eli Un procedimiento para preparar derivados de acidos 7-acilamido-3-halo-cefem-4-carboxilico los esteres y las sales farmaceuticamente aceptables de los mismos
YU36970B (en) * 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
AR205537A1 (es) * 1973-05-10 1976-05-14 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de acido 7-substituido fenilglicinamido - 3 - substituido - 3 - cefem - 4 - carboxilicos
US3994887A (en) * 1973-05-17 1976-11-30 Recherche Et Industrie Therapeutiques (R.I.T.) 7-(3-Substituted ureido) cephalosporins
DK361074A (en:Method) * 1973-07-06 1975-03-03 Fujisawa Pharmaceutical Co
US3998819A (en) * 1973-12-26 1976-12-21 Smithkline Corporation Trifluoroethyl-mercapto, -sulfinyl or -sulfonyl acetamidocephalosporins
US3985746A (en) * 1975-03-25 1976-10-12 E. R. Squibb & Sons, Inc. 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates
US4008230A (en) * 1975-10-29 1977-02-15 Eli Lilly And Company Process for preparing 3-hydroxy cephalosporins

Also Published As

Publication number Publication date
PL191915A1 (pl) 1978-10-23
BG27559A4 (en) 1979-11-12
PL108107B1 (pl) 1980-03-31
AU1698576A (en) 1978-02-23
IL50298A0 (en) 1976-10-31
JPS5225794A (en) 1977-02-25
DK374576A (da) 1977-02-21
NZ181804A (en) 1978-04-28
GB1551931A (en) 1979-09-05
SE7609222L (sv) 1977-02-21
PL110983B1 (en) 1980-08-30
RO75071A (ro) 1980-10-30
AT348119B (de) 1979-01-25
CH622802A5 (en:Method) 1981-04-30
NO762864L (en:Method) 1977-02-22
SU670224A3 (ru) 1979-06-25
FI66619B (fi) 1984-07-31
CH622806A5 (en:Method) 1981-04-30
BG27561A3 (bg) 1979-11-12
RO74667A (ro) 1980-10-30
RO75411A (ro) 1980-11-30
AR214791A1 (es) 1979-07-31
CS193560B2 (en) 1979-10-31
ES450775A1 (es) 1977-10-01
IE43717L (en) 1977-02-20
PT65494A (en) 1976-09-01
CH622805A5 (en:Method) 1981-04-30
AR215247A1 (es) 1979-09-28
HK12083A (en) 1983-04-07
NL7609240A (nl) 1977-02-22
AU501362B2 (en) 1979-06-21
SU847923A3 (ru) 1981-07-15
SU719505A3 (ru) 1980-02-29
JPS6152158B2 (en:Method) 1986-11-12
CA1090331A (en) 1980-11-25
PH12931A (en) 1979-10-17
IL50298A (en) 1979-05-31
RO74668A (ro) 1980-10-30
CS193586B2 (en) 1979-10-31
CS193588B2 (en) 1979-10-31
SU719506A3 (ru) 1980-02-29
FR2321293B1 (en:Method) 1979-01-12
FR2321293A1 (fr) 1977-03-18
CS193589B2 (en) 1979-10-31
PT65494B (en) 1978-02-13
DE2636962A1 (de) 1977-03-03
HU179140B (en) 1982-08-28
BG27561A4 (en) 1979-11-12
FI762381A7 (en:Method) 1977-02-21
SU803862A3 (ru) 1981-02-07
PL108059B1 (pl) 1980-03-31
RO75412A (ro) 1980-12-30
RO74687A (ro) 1980-10-30
SE437990B (sv) 1985-03-25
ZA764980B (en) 1977-07-27
MY8400030A (en) 1984-12-31
PL110876B1 (en) 1980-08-30
FI66619C (fi) 1984-11-12
BG27558A3 (bg) 1979-11-12
CY1165A (en) 1983-06-10
CS193584B2 (en) 1979-10-31
BG27560A4 (en) 1979-11-12
CS193585B2 (en) 1979-10-31
US4069324A (en) 1978-01-17
DE2636962C2 (en:Method) 1987-07-02
CH622804A5 (en:Method) 1981-04-30
ATA615476A (de) 1978-06-15
GR61656B (en) 1978-12-05
SU715029A3 (ru) 1980-02-05
BE845320A (fr) 1977-02-21
NO152510C (no) 1985-10-09
OA05419A (fr) 1981-03-31
IE43717B1 (en) 1981-05-06
NO152510B (no) 1985-07-01
RO69463A (ro) 1980-08-15
CH622803A5 (en:Method) 1981-04-30
SU680650A3 (ru) 1979-08-15

Similar Documents

Publication Publication Date Title
FR2334706B2 (en:Method)
FR2321293B1 (en:Method)
JPS5620212B2 (en:Method)
IN143095B (en:Method)
JPS5241089U (en:Method)
JPS5340251B2 (en:Method)
JPS5197488U (en:Method)
JPS554442Y2 (en:Method)
JPS5750431Y2 (en:Method)
JPS5230049U (en:Method)
JPS51141944U (en:Method)
JPS51153575U (en:Method)
JPS51153932U (en:Method)
CS175313B1 (en:Method)
JPS5245399U (en:Method)
JPS5290565U (en:Method)
CH599661A5 (en:Method)
BG22022A1 (en:Method)
CH600685A5 (en:Method)
CH600331A5 (en:Method)
CH600242A5 (en:Method)
CH599982A5 (en:Method)
CH596879A5 (en:Method)
CH599504A5 (en:Method)
CH599073A5 (en:Method)